Brief: Interpace Diagnostics Group Says Expects To File 2019 Annual Report No Later Than May 14, 2020

Interpace Biosciences

30/03/2020 17:48

March 30 (Reuters) - Interpace Biosciences Inc  IDXG.O :
    * INTERPACE DIAGNOSTICS GROUP - EFFECTS OF COVID-19 HAVE
LIMITED
ABILITIES OF CO’S EMPLOYEES TO CONDUCT NORMAL BUSINESS
ACTIVITIES - SEC FILING
    * INTERPACE DIAGNOSTICS GROUP - EFFECTS OF COVID-19 ON
NORMAL
BUSINESS ACTIVITIES HAS DELAYED CO'S ABILITY TO COMPLETE 2019
ANNUAL REPORT ON FORM 10-K
    * INTERPACE DIAGNOSTICS GROUP - EXPECTS TO FILE 2019 ANNUAL
REPORT
ON FORM 10-K NO LATER THAN MAY 14, 2020

Source text for Eikon:  ID: 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))